Answers are grounded in this paper and cite their sources.
Introduction: The hepatitis B birth dose (HepB-BD) vaccine prevents mother-to-child transmission of the virus. The World Health Organization recommends its administration within 24 hours after birth, targeting 90% vaccination coverage (VC). In the Kabadougou region, administrative VC ranged from 49% to 71% between 2020 and 2023, remaining below national targets. This study aimed to identify the factors associated with this low coverage. Methods: A cross-sectional analytical study was conducted in August 2025 on 450 children born between 2020 and 2025 in Kabadougou, selected by two-stage cluster sampling. Sociodemographic and vaccination data were collected using a KoboCollect questionnaire through interviews, observations, and document review. The outcome variable was non-vaccination with the HepB-BD within three days after birth. Data were analyzed using binary logistic regression in SPSS-27 with α= 5% (p<0.05). Results: HepB-BD vaccination coverage was 68.4% (95% CI: 64.1%-72.7%). No vaccine stockout was reported. On average, five trained health workers were available per health centre (standard deviation: four). Factors significantly associated with non-vaccination were: home birth (adjusted odds ratio [aOR]=5.7; 95% confidence interval [95% CI]:2.3-14.6), each one-year increase in the child’s age (aOR=1.4; 95% CI: 1.2-1.7), unfavourable local beliefs regarding the birth dose (aOR = 4.7; 95% CI: 2.3-9.7), receipt of a vaccination record (aOR=0.1; 95% CI: 0.04-0.5), and maternal counselling on the HepB-BD received during antenatal care (aOR =0.3; 95% CI: 0.2-0.5). Conclusion: The HepB-BD coverage in Kabadougou remains low, driven by home births. Improvement requires promoting facility-based deliveries, community sensitization, and systematic provision of vaccination records.
No takes yet. Share an insight, caveat, or question.
Hué et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: